Update from 2008 ASCO Meeting in Chicago
A study presented during the American Society of Clinical Oncology meeting showed that adding IV infusions of calcium and magnesium to oxaliplatin treatment reduced peripheral neuropathy.
Eloxatin® (oxaliplatin) is part of the FOLFOX treatments for colorectal cancer. As doses accumulate, patients begin to experience tingling and numbness in their hands and feet. Some patients will find it difficult to use their hands for small tasks like buttoning or will have problems with pain, balance or walking. Often patients have to stop treatment before the full benefit is reached because of this difficult side effect. Read the rest of this entry »